News
February 5, 2019

Regenstrief Scientist Says African Americans Have Higher Rate of Alzheimer’s Disease, Quoted in USA Today

Daniel Bateman, M.D., says a number of studies show a higher rate of Alzheimer’s disease in African Americans. He told USA Today there are some hypotheses to explain this.

“There are higher rates of diabetes, hypertension, high cholesterol, heart disease and diabetes in African Americans compared to whites. All of those are risk factors for Alzheimer’s and dementia,” said Dr. Bateman. He points to a 2018 study, which also looked at a number of factors of people who have had a stroke, that found that African Americans had an increased rate for all five types of dementia.

Joanne Pike, vice president of programs for the Alzheimer’s Association in Chicago, says that African Americans are twice as likely to have Alzheimer’s, less likely to receive a diagnosis and more likely to be diagnosed in later stages of the disease. Researchers are looking at many avenues to understand the reasons why.

Regenstrief Institute does a large amount of work in the area of Alzheimer’s and dementia. From testing new care models to decision support and the effects of medication on the brain.  Dr. Bateman’s work is focused on Alzheimer’s disease, specifically innovative approaches to measure and treat behavioral and psychological symptoms of dementia by leveraging technologies. He serves as a co-investigator on the Indiana Alzheimer Disease Center (IADC) Outreach and Recruitment (OR) Core and contributes to the IADC Clinical Core.

Read the USA Today article featuring Dr. Bateman here.

  • Daniel Bateman

Related News

graphic showing some of the results of interhospital transfer for dementia patients

Understanding the impact of transferring patients with dementia between hospitals

Benefits may not always outweigh the risks for this vulnerable population. It is common for individuals seeking medical care

photo of adult caregiver with elderly mother

Brain CareNotes telehealth app supports dementia caregivers

Developed with caregiver input, robust, intuitive app will be available for licensing to health systems, health insurance companies, others

Symposium Moderator Sarah Wiehe welcomes a panel to the stage.

Regenstrief Institute experts participate in Indianapolis HEAL-R symposium

Regenstrief Institute researchers and board members joined partner clinicians, educators and community members at a symposium hosted by the